Advisory Research Inc. increased its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) by 115.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,090 shares of the company’s stock after purchasing an additional 9,161 shares during […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 3,300,000 shares, a growth of 35.2% from the April 30th total of 2,440,000 shares. Based on an average daily volume of 635,600 shares, the […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 2,440,000 shares, an increase of 13.0% from the April 15th total of 2,160,000 shares. Based on an average trading volume of 600,100 shares, the days-to-cover ratio is presently 4.1 days. […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) has received a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price target among […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Rating) CEO Waleed H. Hassanein sold 7,500 shares of the business’s stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $78.13, for a total value of $585,975.00. Following the completion of the transaction, the chief executive officer now directly […]